Literature DB >> 21715130

A review on various heterocyclic moieties and their antitubercular activity.

S Sharma1, P K Sharma, N Kumar, R Dudhe.   

Abstract

Tuberculosis (TB), a contagious infection caused by Mycobacterium tuberculosis, still remains the leading cause of the worldwide death among the infectious disease. Different moieties like pyrazoline, benzimidazol, purines, thiazole, flouroquinolones, quinoxaline, oxadiazol, pyrazol, thiozolidinones and azetidinones have been studied, synthesized and evaluated worldwide against M. tuberculosis to show their antitubercular activity.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21715130     DOI： 10.1016/j.biopha.2011.04.005

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN： 0753-3322            Impact factor:   6.529


  4 in total

1.  Novel drug targets for Mycobacterium tuberculosis: 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis.

Authors:  Mohana Rao Anguru; Ashok Kumar Taduri; Rama Devi Bhoomireddy; Malathi Jojula; Shravan Kumar Gunda
Journal:  Chem Cent J       Date:  2017-07-24       Impact factor: 4.215

2.  Design, synthesis and the biological evaluation of new 1,3-thiazolidine-4-ones based on the 4-amino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one scaffold.

Authors:  Maria Apotrosoaei; Ioana Mirela Vasincu; Maria Dragan; Frédéric Buron; Sylvain Routier; Lenuta Profire
Journal:  Molecules       Date:  2014-09-04       Impact factor: 4.411

3.  3-[1-(3-Hy-droxy-benz-yl)-1H-benzimid-azol-2-yl]phenol dimethyl sulfoxide monosolvate.

Authors:  Magdalena Quezada-Miriel; Alcives Avila-Sorrosa; Juan Manuel German-Acacio; Reyna Reyes-Martínez; David Morales-Morales
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-09-29

4.  Method development and validation of potent pyrimidine derivative by UV-VIS spectrophotometer.

Authors:  Anshu Chaudhary; Anoop Singh; Prabhakar Kumar Verma
Journal:  Org Med Chem Lett       Date:  2014-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.